首页> 外文期刊>Research communications in molecular pathology and pharmacology >Targeting hepatocytes with liposomal interferon-alpha: effect on metallothionein gene induction.
【24h】

Targeting hepatocytes with liposomal interferon-alpha: effect on metallothionein gene induction.

机译:用脂质体干扰素-α靶向肝细胞:对金属硫蛋白基因诱导的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Interferon-alpha (INF-alpha) is the only effective drug for the treatment of chronic hepatitis B. However it can produce severe side effects during treatment. Encapsulation of INF-alpha in liposomes may reduce the side effects and enhance its therapeutic activity. We evaluated the activity of free (nonencapsulated) and liposome-encapsulated INF-alpha on in vitro cultured Chang liver cells by measuring the metallothionein gene (MT-IIA). INF-alpha was encapsulated in different liposomal formulations, Dimyristoylphosphatidylcholine (DMPC), Dioleyl-phosphatidyl-ethanolamine/Dimyristoylphosphatidylcholine (DOPE/DMPC) and DOPE/Dimyristoylphosphatidylglycerol (DOPE/DMPG). Chang liver cells were incubated for 10 hours with 100 units/ml of free or one of the aforementioned liposomal INF-alpha formulations. We also evaluated the extended-time effects of DMPC liposomal formulations of INF-alpha and the non-encapsulated (free) INF-alpha on Chang liver cells after 12, 24 and 36 h of incubation. Total RNA was extracted and signals on Northern blots were densitometrically compared following hybridization with MT-IIA and beta actin probes. All INF-alpha formulations (free and liposomal) induced higher MT-IIA gene levels compared to non-treated control cells. Levels of MT-IIA mRNA expression were 80.9, 73.6, 43.9, and 35.3% over the control for the free, DOPE/DMPG, DMPC and DOPE/DMPC liposomal INF-alpha, respectively. The ratios of MT-IIA mRNA amounts expressed after the Chang liver cells were incubated with INF-alpha encapsulated in DMPC liposomes and the MT-IIA mRNA expressed after incubation with nonencapsulated INF-alpha are 0.7, 0.52 and 0.82 at 12, 24, and 36 hours, respectively. The results indicate that the MT-IIA mRNA level depends on the liposomal formulation of INF-alpha, and the sustained-time effect of the INF-alpha encapsulated in DMPC liposomes is parallel to that of nonencapsulated INF-alpha over a period of 36 hours.
机译:干扰素-α(INF-alpha)是治疗慢性乙型肝炎的唯一有效药物。但是,在治疗过程中它会产生严重的副作用。将INF-α封装在脂质体中可减少副作用并增强其治疗活性。我们通过测量金属硫蛋白基因(MT-IIA)评估了体外培养的Chang肝细胞上游离(未封装)和脂质体封装的INF-alpha的活性。 INF-α被封装在不同的脂质体制剂中,二肉豆蔻酰基磷脂酰胆碱(DMPC),二油基磷脂酰乙醇胺/二肉豆蔻酰基磷脂酰胆碱(DOPE / DMPC)和DOPE /二肉豆蔻酰基磷脂酰甘油(DOPE / DMPG)。将长肝细胞与100单位/ ml的游离脂质或上述脂质体INF-alpha制剂之一孵育10小时。我们还评估了孵育12、24和36小时后DMPCINF-α脂质体制剂和未包封的(游离)INF-α对Chang肝细胞的延长作用。与MT-IIA和β肌动蛋白探针杂交后,提取总RNA并光密度分析比较Northern印迹上的信号。与未处理的对照细胞相比,所有INF-alpha制剂(游离和脂质体)均诱导更高的MT-IIA基因水平。对于游离的DOPE / DMPG,DMPC和DOPE / DMPC脂质体INF-α,MT-IIA mRNA表达水平分别比对照高80.9%,73.6%,43.9%和35.3%。将Chang肝细胞与DMPC脂质体中包裹的INF-α孵育后表达的MT-IIA mRNA的比率,与未包裹INF-α的孵育后表达的MT-IIA mRNA在12、24和12时分别为0.7、0.52和0.82。分别是36个小时。结果表明MT-IIA mRNA水平取决于INF-α的脂质体制剂,并且在DMPC脂质体中封装的INF-alpha的持续时间效应在36小时内与未封装的INF-alpha相似。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号